Product Details for: Zynyz
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
500MG/20ML (25MG/ML)
Single-Dose Vial
351(a)
Zynyz
Rx
Proper Name
retifanlimab-dlwr
retifanlimab-dlwr
BLA Number
761334
761334
Applicant
Incyte Corporation
Incyte Corporation
Original Approval Date
March 22, 2023
March 22, 2023
Date of First Licensure